Lyfebulb, a patient-empowerment platform that connects chronic disease patients, industry, and investors to empower patients and support user-driven innovation, and The New York Stem Cell Foundation...
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF – Robertson Investigator Alumna Dr. Shuibing Chen published her latest work in Cell Stem Cell creating stem cell models of type 2 diabetes in a...
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
Dr. Dieter Egli, NYSCF Senior Research Fellow, discusses his latest somatic cell nuclear transfer (SCNT) research with NYSCF CEO Susan L. Solomon.
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
The NYSCF Research Institute makes stem cell lines available through its stem cell repository. To search for specific cell lines, a specialized stem cell search interface...
NYSCF scientists published a paper today in the journal Diabetes on a breakthrough in diabetes research that could lead to new therapeutic approaches for patients with a...
In a first for the field, NYSCF scientists with Columbia University’s Naomi Berrie Diabetes Center researchers have generated patient-specific beta cells, or insulin-producing cells, that accurately...
In a first for the field, NYSCF scientists with Columbia University's Naomi Berrie Diabetes Center researchers have generated patient-specific beta cells, or insulin-producing cells, that accurately...
Scientists from UCLA have succeeded in modelling ataxia telangiectasia (A-T), a rare genetic disorder, in a dish. This neurodegenerative disease affects 1 in 100,000 worldwide, with...
Led by Douglas Melton, PhD, Harvard Stem Cell Institute Principal Faculty member and NYSCF Medical Advisory Board Executive Committee member, a new Cell study identifies a hormone in...
Walter and Eliza Hall Institute researchers led by Leonard Harrison, DSc, identified and isolated stem cells from the pancreas, and they thenderived insulin-producing beta cells. While...
From the Wall Street Journal, "The New York Stem Cell Foundation gala isn't just a party: It is also a science fair illustrating state-of-the-art stem cell research....
Counter to the prevailing theory that beta cells die-off in Type 2 diabetes patients, NYSCF – Druckenmiller Fellow and postdoctoral research scientist at Columbia University Medical...
Chutima Talchai, PhD, a NYSCF – Druckenmiller Fellow at Columbia University, published work in the March 11th issue of Nature Genetics showing that functional insulin-producing cells...
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco NEW YORK, NY (January 9, 2012) – Susan L....
Discovery Hailed As Step Toward Patient-Specific Treatments for Diabetes, Other Degenerative Diseases NEW YORK, NY (December 9, 2011) – TIME magazine has designated research conducted in the...
New York Stem Cell Foundation, Harvard Stem Cell Institute Announce Joint Effort to Accelerate Drug Discovery NEW YORK, N.Y. (Nov. 17, 2011) — The New York...
Dieter Egli, Ph.D., senior research fellow at the New York Stem Cell Foundation, will speak at the Cell Symposia series meeting on Stem Cell Programming and Reprogramming...
As reported on October 5th in Nature, for the first time scientists have derived embryonic stem cells from individual patients by adding the nuclei of adult...
